DCF — RICHMOND UNIVERSITY MEDICAL CENTER
Enterprise Value: $-1.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.1B
Enterprise Value
$-336.3M
PV of Cash Flows
$-756.9M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $399.0M | $-73.3M | -18.0% | $-90.2M | $-82.0M |
| Year 2 | $410.9M | $-71.4M | -17.0% | $-88.8M | $-73.4M |
| Year 3 | $423.3M | $-69.3M | -16.0% | $-87.3M | $-65.6M |
| Year 4 | $436.0M | $-69.2M | -16.0% | $-87.7M | $-59.9M |
| Year 5 | $449.1M | $-70.2M | -16.0% | $-89.2M | $-55.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$387.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1888112970039032
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5